Results 181 to 190 of about 94,588 (272)

Intravitreal Bevacizumab Alone Vs Combined With Topical Timolol-Dorzolamide or Dorzolamide for Diabetic Macular Edema: A Systematic Review and Meta-Analysis. [PDF]

Clin Ophthalmol
Hubayni RA, Qedair J, Bukhari ZM, Alsudais AS, Badghaish OS, Bawazir RO, AlQahtani AS, Almarzouki H.   +7 more
europepmc   +1 more source

Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.

Ophthalmology (Rochester, Minn.), 2015
Christopher K. Hwang, G. Hubbard, A. Hutchinson, S. Lambert   +3 more
semanticscholar   +1 more source

Factors Affecting Compliance and Visual Outcomes in Patients Receiving Intravitreal Bevacizumab Injections. [PDF]

Cureus
Radhakrishnan O, Agrawal T, Giri N, Gandhi S, Goyal K.   +4 more
europepmc   +1 more source

Effect of panretinal photocoagulation versus intravitreal bevacizumab injection on optic disc microcirculation in patients with diabetic retinopathy. [PDF]

Int J Retina Vitreous
Khojasteh H, Ahadi Fard Moghadam M, Rahimi M, Mirzaei A, Ghassemi F, Takzare A, Faghihi H, Khalili Pour E, Riazi-Esfahani H.   +8 more
europepmc   +1 more source

The treatment of diabetic macular edema with intravitreal bevacizumab in users of the Brazilian public health system. [PDF]

Arq Bras Oftalmol
Ibrahim LF, Soares AN, Costa LA, Domingues TMC, Souza AH.   +4 more
europepmc   +1 more source

Choroidal Response to Intravitreal Bevacizumab Injections in Treatment-Naïve Macular Neovascularization Secondary to Chronic Central Serous Chorioretinopathy. [PDF]

Biomedicines
Rabinovitch D, Shulman S, Goldenberg D, Wang L, Iyer P, Loewenstein A, Igra N, Levine O, Herrera G, Trivizki O.   +9 more
europepmc   +1 more source

Evaluating the causes of retinopathy of prematurity relapse following intravitreal bevacizumab injection. [PDF]

BMC Ophthalmol
Milani AE, Arasteh A, Saeedi-Maleki Z, Niyousha MR, Sahebazamani MA, Brumandpur F.   +5 more
europepmc   +1 more source

A Meta-Analysis of Neurodevelopmental Outcomes following Intravitreal Bevacizumab for the Treatment of Retinopathy of Prematurity.

Neonatology, 2023
Baiad AA, Kherani IZ, Popovic MM, Katsnelson G, Muni RH, Mireskandari K, Tehrani NN, Zhou TE, Kertes PJ.   +8 more
europepmc   +1 more source

Intravitreal Aflibercept for Patients With Diabetic Macular Edema Refractory to Bevacizumab or Ranibizumab: Analysis of Response to Aflibercept

Asia - Pacific Journal of Ophthalmology, 2017
Yen‐Yi Chen, P. Chang, Jia-Kang Wang
semanticscholar   +1 more source

Trabeculectomy with concurrent intravitreal bevacizumab in neovascular glaucoma. [PDF]

Indian J Ophthalmol
Khan SM, Rao A.
europepmc   +1 more source